Raynaud-szindróma, 2011

Translated title of the contribution: Raynaud's syndrome, 2011

Alajos Takáts, Ildikó Garai, Gábor Papp, Tímea Hevér, Emese Csiki, C. András, Zoltán Csiki

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Raynaud's phenomenon is characterized by intense vasospasm of the digital arteries on cold exposure or emotional stress, leading to well-defined colour changes in the skin of the fingers. Behind the clinical manifestations, there is an imbalance between vasoconstrictor and vasodilator factors. It may be primary or secondary to an underlying condition, including autoimmune diseases. Physical examination, nail fold capillaroscopy and immunological tests can differentiate primary forms from secondary ones. The treatment is based on preventing exposure to cold, emotional stress and the administration of certain drugs and, if attacks are present, vasodilators, prostaglandin analogues and anticoagulants may be given. This review focuses on the characteristics of Raynaud's phenomenon and the available diagnostic and therapeutic options.

Original languageHungarian
Pages (from-to)403-409
Number of pages7
JournalOrvosi Hetilap
Volume153
Issue number11
DOIs
Publication statusPublished - Mar 1 2012

Fingerprint

Raynaud Disease
Vasodilator Agents
Psychological Stress
Microscopic Angioscopy
Synthetic Prostaglandins
Immunologic Tests
Vasoconstrictor Agents
Nails
Anticoagulants
Autoimmune Diseases
Fingers
Physical Examination
Arteries
Color
Skin
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Takáts, A., Garai, I., Papp, G., Hevér, T., Csiki, E., András, C., & Csiki, Z. (2012). Raynaud-szindróma, 2011. Orvosi Hetilap, 153(11), 403-409. https://doi.org/10.1556/OH.2012.29321

Raynaud-szindróma, 2011. / Takáts, Alajos; Garai, Ildikó; Papp, Gábor; Hevér, Tímea; Csiki, Emese; András, C.; Csiki, Zoltán.

In: Orvosi Hetilap, Vol. 153, No. 11, 01.03.2012, p. 403-409.

Research output: Contribution to journalArticle

Takáts, A, Garai, I, Papp, G, Hevér, T, Csiki, E, András, C & Csiki, Z 2012, 'Raynaud-szindróma, 2011', Orvosi Hetilap, vol. 153, no. 11, pp. 403-409. https://doi.org/10.1556/OH.2012.29321
Takáts A, Garai I, Papp G, Hevér T, Csiki E, András C et al. Raynaud-szindróma, 2011. Orvosi Hetilap. 2012 Mar 1;153(11):403-409. https://doi.org/10.1556/OH.2012.29321
Takáts, Alajos ; Garai, Ildikó ; Papp, Gábor ; Hevér, Tímea ; Csiki, Emese ; András, C. ; Csiki, Zoltán. / Raynaud-szindróma, 2011. In: Orvosi Hetilap. 2012 ; Vol. 153, No. 11. pp. 403-409.
@article{53b2e8e3b20d4d85b6ff8af60dff16ce,
title = "Raynaud-szindr{\'o}ma, 2011",
abstract = "Raynaud's phenomenon is characterized by intense vasospasm of the digital arteries on cold exposure or emotional stress, leading to well-defined colour changes in the skin of the fingers. Behind the clinical manifestations, there is an imbalance between vasoconstrictor and vasodilator factors. It may be primary or secondary to an underlying condition, including autoimmune diseases. Physical examination, nail fold capillaroscopy and immunological tests can differentiate primary forms from secondary ones. The treatment is based on preventing exposure to cold, emotional stress and the administration of certain drugs and, if attacks are present, vasodilators, prostaglandin analogues and anticoagulants may be given. This review focuses on the characteristics of Raynaud's phenomenon and the available diagnostic and therapeutic options.",
keywords = "Diagnosis, Pathogenesis, Raynaud's syndrome, Therapy",
author = "Alajos Tak{\'a}ts and Ildik{\'o} Garai and G{\'a}bor Papp and T{\'i}mea Hev{\'e}r and Emese Csiki and C. Andr{\'a}s and Zolt{\'a}n Csiki",
year = "2012",
month = "3",
day = "1",
doi = "10.1556/OH.2012.29321",
language = "Hungarian",
volume = "153",
pages = "403--409",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "11",

}

TY - JOUR

T1 - Raynaud-szindróma, 2011

AU - Takáts, Alajos

AU - Garai, Ildikó

AU - Papp, Gábor

AU - Hevér, Tímea

AU - Csiki, Emese

AU - András, C.

AU - Csiki, Zoltán

PY - 2012/3/1

Y1 - 2012/3/1

N2 - Raynaud's phenomenon is characterized by intense vasospasm of the digital arteries on cold exposure or emotional stress, leading to well-defined colour changes in the skin of the fingers. Behind the clinical manifestations, there is an imbalance between vasoconstrictor and vasodilator factors. It may be primary or secondary to an underlying condition, including autoimmune diseases. Physical examination, nail fold capillaroscopy and immunological tests can differentiate primary forms from secondary ones. The treatment is based on preventing exposure to cold, emotional stress and the administration of certain drugs and, if attacks are present, vasodilators, prostaglandin analogues and anticoagulants may be given. This review focuses on the characteristics of Raynaud's phenomenon and the available diagnostic and therapeutic options.

AB - Raynaud's phenomenon is characterized by intense vasospasm of the digital arteries on cold exposure or emotional stress, leading to well-defined colour changes in the skin of the fingers. Behind the clinical manifestations, there is an imbalance between vasoconstrictor and vasodilator factors. It may be primary or secondary to an underlying condition, including autoimmune diseases. Physical examination, nail fold capillaroscopy and immunological tests can differentiate primary forms from secondary ones. The treatment is based on preventing exposure to cold, emotional stress and the administration of certain drugs and, if attacks are present, vasodilators, prostaglandin analogues and anticoagulants may be given. This review focuses on the characteristics of Raynaud's phenomenon and the available diagnostic and therapeutic options.

KW - Diagnosis

KW - Pathogenesis

KW - Raynaud's syndrome

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=84858045419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858045419&partnerID=8YFLogxK

U2 - 10.1556/OH.2012.29321

DO - 10.1556/OH.2012.29321

M3 - Article

VL - 153

SP - 403

EP - 409

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 11

ER -